![]() | ![]() |
Formats:
|
||||||||||||
Copyright © 2005, Cold Spring Harbor Laboratory Press Identification of novel mammalian growth regulatory factors by genome-scale quantitative image analysis 1 Genomics Institute of the Novartis Research Foundation, San Diego, California 92121, USA 2 Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA 3 Vala Sciences, Inc., La Jolla, California 92037, USA 4 Biomedical Research Division, Beckman Coulter, Inc., San Diego, California 92121, USA 5These authors contributed equally to this work. 6Corresponding author. E-mail schanda/at/gnf.org; fax (858) 812-1920. Received March 1, 2005; Accepted June 1, 2005. Freely available online through the Genome Research Immediate Open Access option. This article has been cited by other articles in PMC.Abstract Functional profiling technologies using arrayed collections of genome-scale siRNA and cDNA arrayed libraries enable the comprehensive global analysis of gene function. However, the current repertoire of high-throughput detection methodologies has limited the scope of cellular phenotypes that can be studied. In this report, we describe the systematic identification of mammalian growth-regulatory factors achieved through the integration of automated microscopy, pattern recognition analysis, and cell-based functional genomics. The effects of 7364 human and mouse proteins, encoded by individually arrayed cDNAs, upon proliferation and viability in U2OS osteosarcoma cells were evaluated in a live-cell, kinetic assay using quantitative image analysis. Overexpression of more than 86 cDNAs (1.15%) conferred dramatic increases in the proliferation, as determined cell enumeration. These included several known growth regulators, as well as previously uncharacterized ones (LRRK1, Ankrd25). In addition, novel functional roles for two genes (5033414D02Rik, 2810429O05Rik), now termed Gatp1 and Gatp2, respectively, were identified. Further analysis demonstrated that these encoded proteins promoted cellular proliferation and transformation in primary cells. Conversely, cells depleted for Gatp1 underwent apoptosis upon serum reduction, suggesting that Gatp1 is essential for cell survival under growth-factor-restricted conditions. Taken together, our findings offer new insight into the regulation of cellular growth and proliferation, and demonstrate the value and feasibility of assessing cellular phenotypes through genome-level computational image analysis. Over the last decade, the rapid expansion in genome sequence has led to the identification of genes at a rate that far exceeds the capacity to understand their function (Adams et al. 2000; Lander et al. 2001; Venter et al. 2001; Waterston et al. 2002; Gibbs et al. 2004). Numerous large-scale gene profiling strategies permit the study of RNA expression dynamics at whole-genome levels (Schena et al. 1995; Lockhart and Winzeler 2000; Su et al. 2004) and protein–protein interactions within entire proteomes (Pandey and Mann 2000; Gerlt 2002; MacBeath 2002). Furthermore, several tools aimed at directly assessing gene function in large-scale cell-based assays have recently been developed (Ziauddin and Sabatini 2001; Michiels et al. 2002; Albayrak and Grimm 2003; Arts et al. 2003; Aza-Blanc et al. 2003; Chanda et al. 2003; Chen et al. 2003; Fiscella et al. 2003; Iourgenko et al. 2003; Kiger et al. 2003; Berns et al. 2004; Boutros et al. 2004; Huang et al. 2004; Paddison et al. 2004; Zheng et al. 2004). These collections, comprised of nucleic acid and viral libraries arrayed in an addressable format, apply RNA interference- (RNAi) and overexpression-based methods of probing gene function (Paddison and Hannon 2002; Carpenter and Sabatini 2004; Dorsett and Tuschl 2004; Grimm 2004; Steinmetz and Davis 2004). Although several genome-scale screens using these methodologies have been described, they have largely been restricted to single end-point reporter gene assays that measure whole-well luminescence and fluorescence (Aza-Blanc et al. 2003; Chanda et al. 2003; Chen et al. 2003; Fiscella et al. 2003; Iourgenko et al. 2003; Boutros et al. 2004; Huang et al. 2004; Paddison et al. 2004; Zheng et al. 2004) or visual inspection of image data (Kiger et al. 2003). The high-throughput acquisition and analysis of cellular image data, or high-content screening (HCS), can enable the analysis of complex cellular events not readily measurable with current high-throughput detection methodologies. HCS systems provide an integrated approach whereby image acquisition, processing, and data analysis may be performed in an automated and high-throughput fashion to create a dynamic cellular database (Price et al. 2002; Abraham et al. 2004). This database may then be mined according to specified metrics that represent the cellular phenotype of interest. Data may further be selectively extracted (or “gated”) from individual cells or subpopulations of cells, facilitating the analysis of heterogeneous cell populations. Although this platform presents several potential advantages over current detection methodologies for highly parallel assessments of cellular phenotypes, its utility in cell-based functional genomics applications has not been fully assessed. Toward this end, we used HCS analysis to individually assess the gain-of-function phenotypes conferred by ~7000 genes in cellular proliferation and survival processes through overexpression of their respective cDNAs. This genetic approach yielded a spectrum of activities that affected cellular growth or viability, as measured by cell enumeration, under serum-depleted conditions. We further characterized a subset of these identified clones (LRRK1, Ankrd25, Gatp1, Gatp2, Ptges) in a series of validation assays and confirmed that they positively affect cell growth in multiple cellular backgrounds and induce oncogenic transformation in primary cells. Lastly, we used RNAi methodologies to show that Gatp1, which encodes a highly conserved protein of unknown function, is required for cell survival under reduced-serum conditions. This study demonstrates a successful integration of HCS technologies with high-throughput analyses of gene function, and suggests that these methodologies can facilitate the genetic analysis of cellular phenotypes on a global scale. Results The precise control of cell proliferation and survival is a fundamental process required during mammalian development and is often deregulated in human disease (Brunner et al. 2003; Vermeulen et al. 2003; Alenzi et al. 2004). To identify novel gene activities that may participate in these cellular activities, we performed a genome-scale gain-of-function screen examining cell proliferation and viability under low-serum conditions. An arrayed cDNA expression library comprised of ~7000 full-length mammalian cDNAs was introduced, together with a green fluorescent protein (GFP) expression construct, into U2OS human osteosarcoma cells by means of a high-throughput transfection process (Fig. 1A
To determine baseline transfection efficiencies for individual wells, all cells were marked with a DNA intercalating dye (Hoechst 33342) after 36 h, and image data for total cell counts and GFP-positive cells were collected (read 1) using a high-throughput fluorescence microscopy system (Q3DM EIDAQ100). To facilitate detection of proteins that would effect viability or growth, cells were then transferred to low-serum conditions. This resulted in a reduction of background cellular proliferation, and simultaneous sensitization to pro-apoptotic stimuli (data not shown). Finally, a subsequent imaging step (read 2) was performed to monitor alterations in cell number conferred by the overexpression of these individual cDNAs. Image data were evaluated through the manipulation of a set of software modules (Cytoshop) that enabled the reduction of acquired image data to numerical descriptions of this cellular assay. Initially, nuclear images were corrected for shade distortion and background fluorescence through normalizing spatially segregated intensities and eliminating pixels that fell below the first (significant) mode of the signal distribution, respectively. These “corrected images” were then used to identify individual nuclei in a three-step process. First, to create a binary mask, a linear filter across all corrected nuclear images was applied (Price et al. 1996). This was followed by an automatic histogram-based thresholding step that allowed for the production of binary images (Price et al. 1996). Lastly, a connected components algorithm was then used on these binary mask images to establish separate identifiers for individual nuclei (Price et al. 1996). Approximately 80% of unthresholded objects were successfully classified as cells using this analysis [Supplemental Table 2, see “% identified cells (IC)”], while the remaining 20% represented spatially overlapping sets of nuclei, cell debris, and DNA precipitate. Visual analysis typically resulted in cell numbers within 15% of the results derived from the imaging algorithm (data not shown). Each of the nuclei, also referred to as areas of interest (AOI), and their associated masks, were then inserted into an image database called an “image table.” These tables also stored several properties of each AOI, including corrected pixel values, characteristics of the nuclear masks, spatial location, the coordinates of the AOI's bounding box, as well as others. Since the GFP signal was a cotransfection marker, the corrected GFP-channel (488-nm filter) AOI image pixels were selected relative to the nuclear AOI's centriod coordinates (x, y). These nuclear location values were used to define an expanded bounding box of pixels from the corresponding coordinates (x, y) in the GFP-channel images. The 488-nm AOIs were then formed by clipping the appropriate image pixels from the corrected GFP-channel image and inserting these pixels into the image table in association with their respective nuclear AOIs. Finally, positive transfection events (GFP+ cells) were established in AOIs where the summation of pixels within the GFP channel exceeded a calculated threshold. Thus, cell-by-cell measurements were extracted from dual-emission images corresponding to cell nuclei and GFP expression, and used to identify transfected and untransfected populations in each well. Gene activities that perturbed cellular proliferation kinetics were quantified by recording changes observed in the GFP cotransfected cell population at read 2 relative to read 1. The results included a distribution of growth phenotypes as depicted by a significance factor, or z-score (Fig. 1C
To provide an approximation of false-negative rates in this assay, we analyzed the activities of control wells arrayed in each plate containing known regulators of apoptosis (Bad and Bax, Supplemental Table 2, wells O21–O24 and P21–P24). Of these controls, 71% (113/159) fell outside the cut-off range (z < –3.25) we used in the elucidation of our hits. However, if this standard is relaxed to a threshold of z < –2.5, >90% (144/159) of these control wells would be identified by our methodologies. These results suggest that, although our selection criteria were stringent, the overall performance of the assay and subsequent image analysis is robust and possesses a marginal false-negative rate. Transfection efficiencies at read 1 were observed to be 30.2% on average, but varied widely from well to well, ranging from <1% to >80%. This distribution is a component of within screen variability, which may be derived from several factors in cell-based assay systems. These include heterogeneous cellular responses, plate variations, inconsistencies in library preparation, and other inherent methodological limitations (Lundholt et al. 2003). An important advantage of using image-based methods in functional genomics studies is the ability to differentiate affected and unaffected cells through in silico segregation of mixed cell populations. This enables the precise measurement of signal present only in individual or distinct subpopulations of cells (i.e., transfected cells), and simultaneously comparing their activities to nonresponders (i.e., nontransfected cells) within the same well. To better understand the potential advantages of this analysis methodology, we compared this approach to data generated through solely calculating whole-well fluorescent output, which is comparable to detection by a fluorescent plate reader. We find that image-based analysis of individual cells provides an overall increase in sensitivity, as assessed through a comparison of statistically significant outliers detected by each method (Fig. 1D To ascertain the robustness of the screen and image analysis, and to determine false-positive rates, we next conducted a secondary analysis of proteins that were most proficient in inducing cell death or proliferation under serum-deprived conditions. In all, 92.5% (37/40) of sequence-verified clones demonstrated similar activities to those observed in the initial assay (Supplemental Table 4; data not shown). We postulate that the observed 7.5% false-positive rate results from inherent variabilities associated with high-throughput cellular genomics methodologies. We selected 15 cDNAs that, when overexpressed, exhibited robust proliferation-inductive phenotypes for further investigation (Supplemental Table 5). These included several gene products of unknown function including LRRK1, Ankrd25, Gatp1, and Gatp2, as well as prostaglandin E synthase (Ptges), an inducible enzyme that functions downstream of cyclooxygenase-2 (COX-2) in the prostaglandin E2 (PGE2) biosynthetic pathway (Levy 1997; Williams et al. 1999). To further confirm their proliferative potential under serum-depleted conditions, the activities of these encoded proteins were also examined in a human embryonic kidney cell line, HEK293. Ectopic expression of 11/15 clones reproducibly enhanced growth rates >1.5-fold, as measured by monitoring cellular metabolic activity (Fig. 2A
The abilities of these molecules to increase proliferation rates and induce oncogenic phenotypes were further assessed in primary cells. The retrovirus-mediated transformation of chicken embryo fibroblasts (CEFs) by oncogenes has been shown to result in cell immortalization, anchorage-independent growth, loss of contact inhibition, and increases in cell density at saturation (Bos et al. 1990; Vogt 2001). Avian retroviruses expressing these selected cDNAs were thus used to transduce these factors into primary fibroblasts. Analysis of CEFs stably expressing these genes demonstrated that several of these molecules can confer a growth advantage in this primary cell type (Fig. 2B Expression of LRRK1, Ankrd25, Gatp1, Gatp2, and Ptges was also demonstrated to promote anchorage-independent growth in CEF cells, underscoring their oncogenic potential. While these five clones induced this transformation phenotype to various degrees (Fig. 2D Since forced expression of Gatp1 resulted in increased proliferation rates in both immortalized and primary cells, we further investigated its necessity for cellular growth using RNA interference methodologies. Inhibition of Gatp1 expression was achieved in NIH3T3 cells using synthetic small-interfering RNA (siRNA) oligonucleotides, which reduced target mRNA and protein levels, respectively (Fig. 3A,B
Inspection of Gatp1 peptide sequence showed that this protein contains an uncharacterized conserved domain (KOG4544), and expression analysis of this gene and its homolog across mouse and human tissues, respectively, revealed elevated mRNA levels in both lymphoid and epithelial compartments (Supplemental Fig. 5A,B). Interestingly, these tissues types are associated with cellular proliferation and turnover. Taken together, these findings suggest that this protein, which is highly conserved between human, mouse, Caenorhabditis elegans, and Drosophila melanogaster (Supplemental Fig. 5C), may function as a critical mediator of cellular proliferation and apoptosis in response to levels of extracellular mitotic stimuli. Discussion To date, the functions of approximately one-half of human and one-third of mouse genes have been described in Medline (Su et al. 2004). Many of these ascribed functions are determined based on primary amino acid sequence or expression analysis, and provide little insight into the cellular roles of these genes (Su et al. 2004). Technological advances in the automation of cellular imaging and quantitative image analysis have enabled the application of fluorescence-microscopy-based methods toward high-throughput biological inquiries (Price et al. 2002; Abraham et al. 2004). In comparison to single-measurement well-based assays, HCS systems provide added dimensionalities to the large-scale analyses of gene function, including the ability to record measurements from multiple assay endpoints, from either live or fixed cells, and from both individual cells and cell populations. In the current study, we have used these unique capabilities in a genome-scale functional screen to identify previously unreported modulators of cellular proliferation and transformation. However, several potential biological artifacts and limitations may be associated with this method of analysis. These include potential false negatives derived from inaccuracies in library manipulation, inconsistencies in the expression of the full-length sequenced clones, and possible inactivity of proteins in orthologous biological backgrounds (i.e., mouse cDNAs expressed in human cells). To address some of these concerns and to evaluate a subset of potent growth-inducing proteins (LRRK1, Ankrd25, Gatp1, Gatp2, and Ptges) in additional cellular assays, we used an RCAS retroviral expression system to ectopically express these genes at lower and more physiological levels. Activities of these five encoded proteins were found to augment cellular proliferation in primary cells, and promote phenotypes reflective of oncogenic transformation, raising the possibility that these genes may contribute to the pathogenesis of certain cancers. Further investigation demonstrated that Gatp1 is required for cell survival under serum-restricted conditions. Gatp1 contains an uncharacterized protein domain (KOG4544), and is highly conserved in mammalian species. We have also demonstrated that the pro-proliferative activity of Gatp1 can be recapitulated in both human and avian cell types. Thus, we postulate that Gatp1 is an evolutionarily conserved sensor of extracellular growth cues, and is a critical mediator of the cellular response to these external signals. Our findings further demonstrate the feasibility of conducting high-throughput genomics using fully automated single-cell analysis. We have shown that this image-based approach has considerable advantages over “whole-well” detection methodologies, including significant augmentations in sensitivity, as well as rare-event detection. Furthermore, this technology can uniquely enable the quantitative analysis of certain discrete molecular phenotypes at the level of an individual cell, such as changes in subcellular localization, morphological alterations, cellular migration, or cytoskeletal rearrangements, on a global scale. Although there exists a considerable number of other cellular phenotypes currently addressable by HCS (Price et al. 2002; Abraham et al. 2004), novel assays will likely require the generation of additional image analysis algorithms, or modifications of existing ones. Taken together with the implementation of functional genomics strategies in cell-based assays, these developments should considerably accelerate the discovery of new gene activities, and facilitate the systematic and comprehensive molecular description of biological systems at the cellular level. Methods High-throughput (retro) transfection and image acquisition High-throughput transfections of the expression-ready subset of the Mammalian Gene Collection were performed essentially as described (Chanda et al. 2003; Huang et al. 2004; http://function.gnf.org). This library, consisting of 7364 unique full-length mammalian cDNAs in the mammalian expression vector pCMV-Sport 6, was spotted into 384-well plates such that each well contained 62.5 ng of an individual cDNA of known identity. In a semiautomated process, cDNAs were incubated with a non-liposomal transfection reagent (Fugene6; Roche Applied Sciences) and 20 ng of pZs-Green-C1, a construct that contains the cytomegalovirus immediate-early promoter driving a human codon-optimized variant of the Zoanthus green fluorescent protein (GFP; Clontech). Then ~4000 U2OS human osteosarcoma cells (ATCC) were introduced into each well to complete the transfection process. pZs-Green-C1 was used to mark the cotransfected population. After incubating for 36 h at 37°C and 5% CO2, normal culturing medium (DMEM + 10% fetal calf serum) was exchanged for phenol-red-free DMEM supplemented with 0.5% FCS using the Molecular Devices EMBLA 384-well plate washer. Medium was supplemented with an approximate concentration of 1.0 μg/mL Hoechst 33342 (Molecular Probes) to permit visualization of nuclei. Cell images were then acquired at this time (read 1) using the Beckman-Coulter/Q3DM EIDAQ100 (Q3DM) automated high-content imaging system affixed with a Nikon Super Fluor 10×, 0.5 numerical aperture (NA) objective, and Cohu 640 × 480 pixel charge-coupled device (CCD) camera with 9.9 μm2 pixels. Six images from adjacent fields were acquired in each channel (Hoechst 33342 and GFP), representing 1.81 mm2, or ~17% of the total well area. These conditions typically resulted in the analysis of ~1000 cells per well. For each field, autofocus was first performed and then the Hoechst channel was acquired. Subsequently, upon filter wheel rotation, the GFP channel was also acquired. From the approximate middle of each well, this acquisition sequence was repeated until two rows of three adjacent fields were acquired from both channels. Then, 24 h post-serum withdrawal, this image acquisition procedure was repeated (read 2). Image and data analysis Image analysis was performed using Cytoshop, an integrated image analysis and data visualization tool that generates numerical descriptions of cellular assay data from image sets. We used this software to locate each cell in an image by segmenting images into regions of individual cells. These regions of pixels were then used for the extraction of an assortment of cellular measurements including cell number, size, intensity, and distribution of labeled molecules. Measurements are subsequently collated into a relational database (image table), which may then be analyzed according to desired measurements. Additional details on Cytoshop algorithms may be found in Price et al. (2002) and references therein (Abraham et al. 2004). Image tables were gated using nuclear morphology filters, based on fluorescent intensity and object area and other features, to first identify single cells (vs. cell clusters or cellular debris) in each well (see “Identified Cells” in Supplemental Table 2). This population was subsequently separated into the transfected and untransfected population by uniformly setting GFP intensity thresholds (see “GFP+ Cells” in Supplemental Table 2). The proportion of GFP-positive cells imaged in each well at both reads 1 and 2 was thus derived, and subsequently used to calculate the fractional change in GFP signal in each well [fractional change = (fraction of GFP-positive cells at read 2)/(fraction of GFP-positive cells at read 1)]. Fractional changes were then log-transformed (log10) and divided by a constant (log102) to reflect the number of population doublings (alternatively halvings) observed from read 1 to read 2. These values were used to derive z-scores by calculating the variance (in standard deviations) from the trimmed plate mean for each value in the analysis set. cDNAs that enabled continued cell proliferation under low-serum conditions with an arbitrarily selected z-score threshold (>3.0) were selected for further analysis. Those that reproducibly elevated fractional change relative to vector control were retained for additional validation studies. Fractional changes of GFP fluorescence (Fig. 1D Validation of screen hits using the CellTiter-Glo Luminescent Cell Viability Assay To provide additional validation, the effect of primary screen hits on cell proliferation was assessed in an alternate cellular background using the CellTiter-Glo Luminescent Cell Viability Assay (Promega). Briefly, 62.5 ng of each screen hit was spotted into 384-well plate format and retrotransfected into ~2000 HEK293 cells using Fugene6. Transfections were performed at low (DMEM, 0.5% FCS) serum conditions, and incubated for 48 h at 37°C. CellTiter-Glo reagent was then added to cells according to the manufacturer's specifications, and luminescence output was measured using the Acquest Plate Reader (LJL Biosystems). The relative luminescence recorded in each well, which correlates with the number of metabolically active cells, was normalized to pcDNA6 vector-transfected (Invitrogen) control wells. Construction of growth activator clone-expressing chicken embryo fibroblast cell lines and growth kinetic analysis Transfer of cDNA clones into Gateway-compatible, subtype A replication-competent avian sarcoma leucosis virus vectors was performed using Gateway LR clonase (Invitrogen). Upon sequence verification, recombinant viral vectors were transfected into primary chicken embryo fibroblasts using DMSO shock as described (Bister et al. 1977) to generate stable growth activator-expressing cell lines. Viral supernatants were harvested from stable lines and used to infect fresh CEFs (Bister et al. 1977; Bos et al. 1990). After serially passaging infected cells three times, growth kinetic analyses were performed using the Beckman-Coulter/Q3DM EIDAQ100 quantitative high-throughput fluorescence microscopy system. Briefly, cells were seeded at ~500 cells per well in 384-well plate format, and maintained for 5 d in culture at 37°C in Ham F10 cloning media (Bister et al. 1977). Cells were visualized by Hoechst 33342 staining, and growth was monitored by imaging daily using a 10×, 0.5 NA objective, and Cohu CCD camera. Effects of stably expressing select growth-activator cDNA clones were quantitated using Cytoshop by first gating image data with a nuclear morphology filter to identify individual cells, and subsequently setting nuclear staining intensity thresholds. Focus formation and soft agar assays in primary chicken embryo fibroblasts Focus formation assays were performed as described (Bister et al. 1977; Bos et al. 1990). CEFs were seeded at a density of 5 × 105 cells/well of a six-well plate and infected with activator-expressing viruses. Cells were then overlaid with agar medium and maintained in culture for 3–4 wk. Foci were subsequently visualized by staining with crystal violet. Soft agar assays were performed as described (Bister et al. 1977). Transfection and validation of siRNAs A synthetic siRNA SMARTpool, comprised of a pool of four independent SMARTselected siRNA duplexes targeting Gatp1, was purchased from Dharmacon. The sequences of individual siRNAs in the pool that demonstrated efficacy are 5′-AACAACAGGA GUUCAUGGUUA-3′ and 5′-AACCAACAGGAGUUCAUGGUU-3′. All siRNA transfections were performed at 20 or 50 nM concentration using TransIT-TKO following the manufacturer's specifications (Mirus). Transfection efficiencies were determined by performing parallel transfections with a Cy3-conjugated siRNA targeting the GL2 firefly luciferase gene (Dharmacon), and estimated to be >90% by fluorescence microscopy. To assess the efficacy of target protein knockdown conferred by the SMARTpool, cDNA clone Gatp1 was Flag-epitope tagged and transfected in the presence or absence of the indicated SMARTpool/siRNA into NIH3T3 mouse embryo fibroblasts (ATCC). Approximately 2 × 105 NIH3T3 cells were seeded into six-well plates and either mock-transfected, or transfected with an siRNA targeting Gatp1 or GL2. After incubating for 24 h, medium was replaced, and cells were transfected with Flag-Gatp1 using TransIT-3T3 reagent (Mirus) according to the manufacturer's instructions. Then, 48 h post-transfection with DNA, cells were harvested, and the resultant extracts were resolved on 10% NuPAGE Novex Bis-Tris gels (Invitrogen). Immunoblot analysis was performed upon protein transfer to polyvinylidine difluoride membranes (Amersham Biosciences), using the M2 anti-Flag (Sigma-Aldrich) and D-10 anti-β-tubulin monoclonal antibodies (Santa Cruz Biotechnology). Target mRNA knockdown was further validated using semiquantitative RT-PCR. RNAs from siRNA-transfected cells were harvested using the RNeasy mini-kit (Qiagen). cDNA was then produced using Superscript III reverse transcriptase (Invitrogen) with 1 μg of total RNA as template. Ensuing cDNA products were used in PCR reactions with primer sets 5′-ATATCGCTGCGCTG GTCGTC-3′ and 5′-ACATAGGAGTCCTTCTGACC-3′ to amplify cytoplasmic β-actin, and 5′-GGAGTTCATGGTTACGCATG-3′and 5′-TAGGAACGAGAAAGGCTGGC-3′ to amplify the RIKEN cDNA 5033414D02 gene. Requirement for activator clone Gatp1 in cell growth and survival The effect of gene knockdown on cellular growth rates was determined using imaging methods similar to those described above. Briefly, ~1000 NIH3T3 cells were seeded into 384-well tissue culture plates under normal (10%) and low (1%) serum conditions, and transfected with the indicated siRNA. Transfected cells were maintained in culture for 4 d at 37°C, and cell growth was monitored daily by quantitative imaging. Cell cycle studies were additionally performed using these image sets in Cytoshop (Wan et al. 2004). Histograms evaluating total nuclear intensity and event frequency for representative wells were used to define fluorescence boundaries for sub-G1, G1, and S/G2/M populations. Fractions of cells in each group were determined for all wells, and replicate wells were averaged for each condition. siRNA-transfected NIH3T3 cells were evaluated for the induction of apoptosis using the Apo-ONE Homogeneous Caspase-3/7 Assay kit (Promega) according to the manufacturer's instructions. Cells treated with 1 μg/mL recombinant TRAIL (Calbiochem) for 4 h were analyzed in parallel to serve as a positive control (Aza-Blanc et al. 2003). Acknowledgments We thank Hilmar Lapp, Nicole Johnson, Abel Gutierrez, Paul DeJesus, Myleen Medina, and Brendan Smith for providing excellent technical assistance; and Trey Sato, Garrett Hampton, and Tim Moran for helpful comments on the manuscript and advice. This work is supported by funding from the Novartis Research Foundation and National Institutes of Health research grants CA42564, CA79616, and CA78230 to P.K.V. Notes [Supplemental material is available online at www.genome.org.] Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.3889305. Article published online before print in July 2005. Freely available online through the Genome Research Immediate Open Access Option. References
Web site references
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Science. 2000 Mar 24; 287(5461):2185-95.
[Science. 2000]Nature. 2001 Feb 15; 409(6822):860-921.
[Nature. 2001]Science. 2001 Feb 16; 291(5507):1304-51.
[Science. 2001]Nature. 2002 Dec 5; 420(6915):520-62.
[Nature. 2002]Nature. 2004 Apr 1; 428(6982):493-521.
[Nature. 2004]Trends Biotechnol. 2004 Jan; 22(1):15-22.
[Trends Biotechnol. 2004]Cell Prolif. 2003 Jun; 36(3):131-49.
[Cell Prolif. 2003]Cytometry. 1996 Dec 1; 25(4):303-16.
[Cytometry. 1996]Trends Cell Biol. 2001 Dec; 11(12):526-34.
[Trends Cell Biol. 2001]Nat Rev Cancer. 2002 Sep; 2(9):647-56.
[Nat Rev Cancer. 2002]Jpn J Cancer Res. 1999 Mar; 90(3):286-93.
[Jpn J Cancer Res. 1999]J Biol Chem. 1998 Apr 3; 273(14):7783-6.
[J Biol Chem. 1998]Leukemia. 2002 Apr; 16(4):444-54.
[Leukemia. 2002]J Biomol Screen. 2003 Oct; 8(5):566-70.
[J Biomol Screen. 2003]FASEB J. 1997 Mar; 11(4):234-47.
[FASEB J. 1997]Oncogene. 1999 Dec 20; 18(55):7908-16.
[Oncogene. 1999]Genes Dev. 1990 Oct; 4(10):1677-87.
[Genes Dev. 1990]Oncogene. 2001 Apr 30; 20(19):2365-77.
[Oncogene. 2001]Chem Biol. 2004 Feb; 11(2):247-59.
[Chem Biol. 2004]Trends Cell Biol. 2001 Dec; 11(12):526-34.
[Trends Cell Biol. 2001]Nat Rev Cancer. 2002 Sep; 2(9):647-56.
[Nat Rev Cancer. 2002]Proc Natl Acad Sci U S A. 2004 Apr 20; 101(16):6062-7.
[Proc Natl Acad Sci U S A. 2004]Trends Biotechnol. 2004 Jan; 22(1):15-22.
[Trends Biotechnol. 2004]Trends Biotechnol. 2004 Jan; 22(1):15-22.
[Trends Biotechnol. 2004]Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12153-8.
[Proc Natl Acad Sci U S A. 2003]Proc Natl Acad Sci U S A. 2004 Mar 9; 101(10):3456-61.
[Proc Natl Acad Sci U S A. 2004]Trends Biotechnol. 2004 Jan; 22(1):15-22.
[Trends Biotechnol. 2004]Virology. 1977 Oct 15; 82(2):431-48.
[Virology. 1977]Virology. 1977 Oct 15; 82(2):431-48.
[Virology. 1977]Genes Dev. 1990 Oct; 4(10):1677-87.
[Genes Dev. 1990]Virology. 1977 Oct 15; 82(2):431-48.
[Virology. 1977]Genes Dev. 1990 Oct; 4(10):1677-87.
[Genes Dev. 1990]Chem Biol. 2004 Feb; 11(2):247-59.
[Chem Biol. 2004]Mol Cell. 2003 Sep; 12(3):627-37.
[Mol Cell. 2003]Virology. 1977 Oct 15; 82(2):431-48.
[Virology. 1977]Genes Dev. 1990 Oct; 4(10):1677-87.
[Genes Dev. 1990]Chem Biol. 2004 Feb; 11(2):247-59.
[Chem Biol. 2004]